
About Fineotex Chemical Limited
Data last updated:
Fineotex Chemical Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the specialty chemicals segment of the chemicals and materials sector. It was incorporated on 30 January 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN L24100MH2004PLC144295. Its GSTIN is 27AAACF8360M1Z9 (Maharashtra). The company holds 2 GST registrations, of which 1 is active. It is a listed company as per MCA records. Its shares are listed on BSE: 533333 and NSE: FCL.
The company has an authorised share capital of ₹120 Cr and a paid-up capital of ₹116.45 Cr. It was formerly known as Fineotex Chemical Private Limited. It is led by directors including Surendra Deviprasad Tibrewala (Managing Director) and Aarti Mitesh Jhunjhunwala (Whole-Time Director).
Its last annual general meeting (AGM) was held on 11 September 2026, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Mumbai, Maharashtra.
As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹772.23 Cr, a growth of 44.8% compared to the previous year. For the same year it recorded a net profit of ₹108.77 Cr (net margin 14.1%) and EBITDA of ₹134.76 Cr (EBITDA margin 17.5%). The net worth stands at ₹882.43 Cr (up 20.7% YoY). Total assets are valued at ₹950.19 Cr (up 28.2% YoY).
The company has about 92 employees on its provident fund (EPFO) records. Its group structure includes 3 subsidiaries.
The company is associated with 1 brand: Fineotex Chemical. As per MCA filings, the company has open charges of ₹39.31 Cr and satisfied charges of ₹19.69 Cr on record. Court records list 10 cases involving the company, including 7 filed by the company and 3 filed against it; 6 cases are pending. The company has 159 deals on record (156 market trades, 1 buyback, 1 funding round), with disclosed funding of ₹342.55 Cr; the latest was in May 2026. Its 7 peer companies in the Chemicals industry (Specialty Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 4 smaller; the largest is H.B. Fuller India Adhesives Private Limited with revenue of ₹575.65 Cr.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website fineotex.com.
Company details
CIN history
Fineotex Chemical has one previous CIN (Corporate Identification Number): U24100MH2004PLC144295. The current CIN is L24100MH2004PLC144295, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L24100MH2004PLC144295 | Current |
| U24100MH2004PLC144295 | Previous |
Contact details
Fineotex Chemical Limited's registered office is in Mumbai, Maharashtra. Its website is fineotex.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressLevel 4 Ariisto House Junction Of Telli Galli & Phadke Road, Opposite Hubtown Solaris Andheri East, Mumbai, Maharashtra, India – 400069
- IndustryChemicals and Materials, Specialty Chemicals
To see the full contact details of Fineotex Chemical Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Fineotex Chemical operates one associated brand: Fineotex Chemical. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Chemicals for textiles, construction, and water-treatment are manufactured. | fineotex.com |
Business activity
The main business activity of Fineotex Chemical is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Fineotex Chemical Limited, buy the company report.
Financials of Fineotex Chemical Limited
FY 2025-26 filings availableFineotex Chemical Limited reported revenue of ₹772.23 Cr (up 44.8% YoY) for FY 2025-26.
Financial Highlights
FY 2025-26 · ConsolidatedRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 772 | 533 | 569 | 517 | 368 | 219 | 196 |
| Revenue growth | +44.8% | -6.3% | +10.1% | +40.4% | +68.5% | +11.3% | - |
| EBITDA | 135 | 127 | 148 | 113 | 71.20 | 40.57 | 22.16 |
| EBITDA margin | +17.5% | +23.9% | +26.1% | +21.8% | +19.3% | +18.6% | +11.3% |
| Profit before tax | 153 | 141 | 158 | 115 | 73.29 | 55.87 | 21.97 |
| Net profit | 109 | 108 | 120 | 88.31 | 55.17 | 42.59 | 20.75 |
| Net profit margin | +14.1% | +20.3% | +21.1% | +17.1% | +15.0% | +19.5% | +10.6% |
| EPS (₹) | 0.93 | 9.44 | 10.82 | 7.97 | 4.98 | 3.85 | 1.17 |
| Balance sheet | |||||||
| Total assets | 950 | 741 | 460 | 364 | 272 | 220 | 180 |
| Net worth | 882 | 731 | 447 | 349 | 262 | 209 | 170 |
| Total debt | 8.20 | 0.22 | 5.19 | 7.28 | 1.91 | 3.47 | 3.03 |
| Cash & bank | 46.18 | 41.70 | 39.92 | 59.57 | 38.06 | 33.91 | 17.93 |
| Net working capital | 347 | 194 | 163 | 167 | 166 | 119 | 78.62 |
| Cash flow | |||||||
| Cash from operations | (23.81) | 69.33 | 97.04 | 107 | 13.38 | 9.20 | 28.36 |
| Cash from investing | 113 | (273) | (47.10) | (99.47) | 0.67 | (7.25) | (18.63) |
| Cash from financing | (62.52) | 176 | (23.91) | (6.44) | (5.66) | (4.44) | (3.88) |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 377 | 314 | 184 | 138 | 137 | 120 | 126 | 146 |
| Revenue growth (YoY) | +174.8% | +161.9% | +45.9% | -5.5% | -3.4% | - | - | - |
| Other income | 10.09 | 9.46 | 6.75 | 7.72 | 9.14 | 7.55 | 4.99 | 6.90 |
| EBITDA | 59.15 | 43.68 | 34.84 | 31.03 | 25.19 | 21.29 | 34.29 | 36.39 |
| EBITDA margin | +15.7% | +13.9% | +19.0% | +22.5% | +18.4% | +17.8% | +27.2% | +25.0% |
| Depreciation | 4.39 | 4.40 | 3.33 | 3.01 | 2.69 | 2.01 | 2.59 | 2.37 |
| Interest | 0.10 | 0.63 | 0.23 | 0.34 | 0.16 | 0.40 | 0.20 | 0.22 |
| Profit before tax | 64.75 | 48.11 | 38.03 | 35.40 | 31.48 | 26.43 | 36.49 | 40.70 |
| Tax | 16.54 | 4.32 | 7.91 | 9.32 | 6.47 | 6.29 | 8.65 | 8.63 |
| Net profit | 48.21 | 43.79 | 30.12 | 26.08 | 25.01 | 20.14 | 27.84 | 32.07 |
| EPS (₹) | 0.41 | 0.38 | 0.26 | 2.27 | 2.18 | 1.76 | 2.43 | 2.80 |
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 397 | 439 | 419 | 296 | 250 | 129 | 129 |
| Revenue growth | -9.6% | +4.8% | +41.8% | +18.2% | +93.1% | +0.5% | - |
| EBITDA | 81.29 | 106 | 113 | 61.00 | 53.38 | 31.22 | 15.18 |
| EBITDA margin | +20.5% | +24.1% | +27.1% | +20.6% | +21.4% | +24.1% | +11.8% |
| Profit before tax | 113 | 125 | 141 | 67.72 | 56.76 | 45.00 | 17.04 |
| Net profit | 91.90 | 97.23 | 111 | 52.03 | 43.98 | 35.98 | 18.04 |
| Net profit margin | +23.2% | +22.1% | +26.4% | +17.6% | +17.6% | +27.8% | +14.0% |
| EPS (₹) | 0.79 | 8.49 | 9.99 | 4.70 | 3.97 | 3.25 | 0.97 |
| Balance sheet | |||||||
| Total assets | 757 | 631 | 365 | 278 | 225 | 185 | 151 |
| Net worth | 754 | 629 | 358 | 270 | 222 | 181 | 148 |
| Total debt | 0.00 | 0.05 | 5.19 | 7.28 | 1.88 | 3.41 | 2.84 |
| Cash & bank | 17.58 | 26.36 | 21.40 | 32.63 | 23.73 | 11.21 | 2.45 |
| Net working capital | 176 | 146 | 117 | 113 | 123 | 81.58 | 47.88 |
| Cash flow | |||||||
| Cash from operations | (73.11) | 58.10 | 68.60 | 66.29 | 13.47 | (0.83) | 22.21 |
| Cash from investing | 62.92 | (257) | (11.09) | (68.57) | 7.09 | (6.20) | (17.45) |
| Cash from financing | 32.01 | 173 | (22.85) | (5.00) | (3.84) | (2.72) | (2.06) |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 85.15 | 97.60 | 96.47 | 105 | 98.26 | 108 | 109 | 115 |
| Revenue growth (YoY) | -13.3% | -9.6% | -11.8% | -9.4% | -7.8% | - | - | - |
| Other income | 10.78 | 7.41 | 11.28 | 12.43 | 9.97 | 7.65 | 4.53 | 11.06 |
| Total expenses | 69.45 | 78.35 | 74.56 | 81.43 | 81.26 | 87.79 | 79.67 | 85.65 |
| EBITDA | 15.70 | 19.25 | 21.91 | 23.12 | 17.00 | 20.16 | 29.64 | 29.71 |
| EBITDA margin | +18.4% | +19.7% | +22.7% | +22.1% | +17.3% | +18.7% | +27.1% | +25.8% |
| Depreciation | 2.18 | 2.13 | 2.15 | 2.10 | 2.01 | 1.86 | 1.89 | 1.74 |
| Interest | 0.19 | 0.17 | 0.12 | 0.13 | 0.11 | 0.21 | 0.17 | 0.11 |
| Profit before tax | 24.11 | 24.36 | 30.92 | 33.32 | 24.85 | 25.74 | 32.11 | 38.92 |
| Tax | 3.58 | 3.23 | 5.27 | 8.11 | 4.95 | 6.29 | 7.63 | 7.47 |
Financial Statements
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 377 | 314 | 184 | 138 | 137 | 120 | 126 | 146 |
| Revenue growth (YoY) | +174.8% | +161.9% | +45.9% | -5.5% | -3.4% | - | - | - |
| Other income | 10.09 | 9.46 | 6.75 | 7.72 | 9.14 | 7.55 | 4.99 | 6.90 |
| EBITDA | 59.15 | 43.68 | 34.84 | 31.03 | 25.19 | 21.29 | 34.29 | 36.39 |
| EBITDA margin | +15.7% | +13.9% | +19.0% | +22.5% | +18.4% | +17.8% | +27.2% | +25.0% |
| Depreciation | 4.39 | 4.40 | 3.33 | 3.01 | 2.69 | 2.01 | 2.59 | 2.37 |
| Interest | 0.10 | 0.63 | 0.23 | 0.34 | 0.16 | 0.40 | 0.20 | 0.22 |
| Profit before tax | 64.75 | 48.11 | 38.03 | 35.40 | 31.48 | 26.43 | 36.49 | 40.70 |
| Tax | 16.54 | 4.32 | 7.91 | 9.32 | 6.47 | 6.29 | 8.65 | 8.63 |
| Net profit | 48.21 | 43.79 | 30.12 | 26.08 | 25.01 | 20.14 | 27.84 | 32.07 |
| EPS (₹) | 0.41 | 0.38 | 0.26 | 2.27 | 2.18 | 1.76 | 2.43 | 2.80 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 772 | 533 | 569 | 517 | 368 | 219 | 196 |
| Revenue growth | +44.8% | -6.3% | +10.1% | +40.4% | +68.5% | +11.3% | - |
| Other income | 33.07 | 24.31 | 16.54 | 7.30 | 5.52 | 17.49 | 1.61 |
| Total expenses | 637 | 406 | 421 | 404 | 297 | 178 | 174 |
| Employee cost | 40.35 | 24.32 | 21.16 | 18.38 | 13.58 | 8.86 | 8.73 |
| EBITDA | 135 | 127 | 148 | 113 | 71.20 | 40.57 | 22.16 |
| EBITDA margin | +17.5% | +23.9% | +26.1% | +21.8% | +19.3% | +18.6% | +11.3% |
| Depreciation | 13.42 | 9.22 | 6.02 | 4.28 | 2.51 | 1.47 | 1.17 |
| Interest | 1.36 | 1.07 | 1.33 | 0.82 | 0.92 | 0.72 | 0.63 |
| Profit before tax | 153 | 141 | 158 | 115 | 73.29 | 55.87 | 21.97 |
| Tax | 28.02 | 32.03 | 36.55 | 25.24 | 16.40 | 11.31 | 7.65 |
| Net profit | 109 | 108 | 120 | 88.31 | 55.17 | 42.59 | 20.75 |
| Net profit margin | +14.1% | +20.3% | +21.1% | +17.1% | +15.0% | +19.5% | +10.6% |
| EPS (₹) | 0.93 | 9.44 | 10.82 | 7.97 | 4.98 | 3.85 | 1.17 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 116 | 22.92 | 22.15 | 22.15 | 22.15 | 22.15 | 22.26 |
| Reserves & surplus | 766 | 708 | 425 | 327 | 240 | 187 | 147 |
| Shareholders' funds (net worth) | 882 | 731 | 447 | 349 | 262 | 209 | 170 |
| Minority interest | 57.30 | 7.55 | 6.47 | 7.01 | 7.25 | 6.75 | 6.29 |
| Secured loans | 4.38 | 0.22 | 5.19 | 7.28 | 1.88 | 3.41 | 2.84 |
| Unsecured loans | 3.82 | 0.00 | 0.00 | 0.00 | 0.03 | 0.06 | 0.19 |
| Total debt | 8.20 | 0.22 | 5.19 | 7.28 | 1.91 | 3.47 | 3.03 |
| Total liabilities | 950 | 741 | 460 | 364 | 272 | 220 | 180 |
| Assets | |||||||
| Gross block | 355 | 253 | 159 | 110 | 91.42 | 64.27 | 44.06 |
| Net block | 278 | 179 | 141 | 98.88 | 84.04 | 59.40 | 40.61 |
| Capital work in progress | 2.18 | 21.08 | 0.00 | 0.36 | 0.00 | 4.60 | 0.63 |
| Investments | 317 | 330 | 147 | 89.33 | 17.31 | 32.38 | 52.47 |
| Inventories | 155 | 64.48 | 50.11 | 47.29 | 59.59 | 28.75 | 21.09 |
| Sundry debtors | 290 | 116 | 139 | 101 | 111 | 82.67 | 53.85 |
| Cash & bank balances | 46.18 | 41.70 | 39.92 | 59.57 | 38.06 | 33.91 | 17.93 |
| Loans & advances | 56.99 | 38.90 | 18.24 | 15.67 | 23.26 | 19.44 | 14.03 |
| Total current assets | 548 | 261 | 247 | 224 | 232 | 165 | 107 |
| Total current liabilities | 201 | 66.88 | 84.22 | 56.57 | 66.16 | 46.14 | 28.28 |
| Net working capital | 347 | 194 | 163 | 167 | 166 | 119 | 78.62 |
| Total assets | 950 | 741 | 460 | 364 | 272 | 220 | 180 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 29.07 | 56.32 | 30.29 | 28.93 | 20.54 | 23.03 | 17.18 |
| Net cash from operating activities | (23.81) | 69.33 | 97.04 | 107 | 13.38 | 9.20 | 28.36 |
| Net cash from investing activities | 113 | (273) | (47.10) | (99.47) | 0.67 | (7.25) | (18.63) |
| Net cash from financing activities | (62.52) | 176 | (23.91) | (6.44) | (5.66) | (4.44) | (3.88) |
| Net change in cash | 27.05 | (27.24) | 26.03 | 1.36 | 8.39 | (2.49) | 5.85 |
| Closing cash | 46.18 | 41.70 | 39.92 | 59.57 | 38.06 | 33.91 | 17.93 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +44.8% | -6.3% | +10.1% | +40.4% | +68.5% | +11.3% | - |
| EBITDA growth | +5.9% | -14.3% | +31.8% | +58.1% | +75.5% | +83.1% | - |
| PBT growth | +8.4% | -10.4% | +37.3% | +56.6% | +31.2% | +154.3% | -34.7% |
| Net income growth | +0.5% | -9.7% | +35.7% | +60.1% | +29.5% | +105.3% | - |
| Revenue CAGR (3Y) | +14.3% | +13.1% | +37.6% | +38.1% | +26.4% | +15.7% | +15.6% |
| EBITDA CAGR (3Y) | +6.2% | +21.4% | +54.1% | +71.9% | +28.1% | +10.6% | -9.1% |
| Profitability & leverage | |||||||
| Net income margin | +16.2% | +20.5% | +21.3% | +17.3% | +15.5% | +20.4% | +7.3% |
| Return on capital employed | +19.0% | +24.0% | +39.2% | +37.2% | +31.0% | +29.3% | +21.0% |
| Return on net worth | +15.5% | +18.5% | +30.4% | +29.3% | +24.1% | +23.5% | +13.4% |
| Debt / equity | 0.01 | 0.00 | 0.02 | 0.02 | 0.01 | 0.02 | 0.02 |
| Long-term debt / equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest cover | 1.12 | 0.91 | 0.93 | 0.76 | 1.34 | 1.84 | 3.00 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 2.54 | 2.59 | 4.23 | 5.12 | 4.73 | 4.03 | 4.77 |
| Inventory turnover | 7.05 | 9.31 | 11.68 | 9.67 | 8.34 | 8.77 | 8.50 |
| Debtors turnover | 3.80 | 4.19 | 4.74 | 4.87 | 3.80 | 3.20 | 3.81 |
| EPS (₹) | 0.93 | 9.44 | 10.82 | 7.97 | 4.98 | 3.85 | 1.17 |
| Dividend per share (₹) | 0.45 | 0.80 | 1.60 | 0.80 | 0.40 | 0.30 | 0.05 |
| Book value per share (₹) | 7.58 | 63.81 | 40.36 | 31.48 | 23.67 | 18.90 | 15.25 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 85.15 | 97.60 | 96.47 | 105 | 98.26 | 108 | 109 | 115 |
| Revenue growth (YoY) | -13.3% | -9.6% | -11.8% | -9.4% | -7.8% | - | - | - |
| Other income | 10.78 | 7.41 | 11.28 | 12.43 | 9.97 | 7.65 | 4.53 | 11.06 |
| Total expenses | 69.45 | 78.35 | 74.56 | 81.43 | 81.26 | 87.79 | 79.67 | 85.65 |
| EBITDA | 15.70 | 19.25 | 21.91 | 23.12 | 17.00 | 20.16 | 29.64 | 29.71 |
| EBITDA margin | +18.4% | +19.7% | +22.7% | +22.1% | +17.3% | +18.7% | +27.1% | +25.8% |
| Depreciation | 2.18 | 2.13 | 2.15 | 2.10 | 2.01 | 1.86 | 1.89 | 1.74 |
| Interest | 0.19 | 0.17 | 0.12 | 0.13 | 0.11 | 0.21 | 0.17 | 0.11 |
| Profit before tax | 24.11 | 24.36 | 30.92 | 33.32 | 24.85 | 25.74 | 32.11 | 38.92 |
| Tax | 3.58 | 3.23 | 5.27 | 8.11 | 4.95 | 6.29 | 7.63 | 7.47 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 397 | 439 | 419 | 296 | 250 | 129 | 129 |
| Revenue growth | -9.6% | +4.8% | +41.8% | +18.2% | +93.1% | +0.5% | - |
| Other income | 41.09 | 27.49 | 32.42 | 10.66 | 6.14 | 15.52 | 3.26 |
| Total expenses | 316 | 334 | 305 | 235 | 197 | 98.26 | 114 |
| Employee cost | 24.02 | 21.10 | 18.23 | 15.64 | 11.50 | 6.96 | 6.92 |
| EBITDA | 81.29 | 106 | 113 | 61.00 | 53.38 | 31.22 | 15.18 |
| EBITDA margin | +20.5% | +24.1% | +27.1% | +20.6% | +21.4% | +24.1% | +11.8% |
| Depreciation | 8.39 | 7.16 | 4.52 | 3.37 | 2.25 | 1.42 | 1.11 |
| Interest | 0.53 | 0.59 | 0.81 | 0.57 | 0.51 | 0.32 | 0.29 |
| Profit before tax | 113 | 125 | 141 | 67.72 | 56.76 | 45.00 | 17.04 |
| Tax | 21.56 | 28.19 | 29.92 | 15.69 | 12.78 | 9.02 | 6.25 |
| Net profit | 91.90 | 97.23 | 111 | 52.03 | 43.98 | 35.98 | 18.04 |
| Net profit margin | +23.2% | +22.1% | +26.4% | +17.6% | +17.6% | +27.8% | +14.0% |
| EPS (₹) | 0.79 | 8.49 | 9.99 | 4.70 | 3.97 | 3.25 | 0.97 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 116 | 22.92 | 22.15 | 22.15 | 22.15 | 22.15 | 22.26 |
| Reserves & surplus | 638 | 606 | 336 | 247 | 200 | 159 | 125 |
| Shareholders' funds (net worth) | 754 | 629 | 358 | 270 | 222 | 181 | 148 |
| Secured loans | 0.00 | 0.05 | 5.19 | 7.28 | 1.88 | 3.41 | 2.74 |
| Unsecured loans | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.10 |
| Total debt | 0.00 | 0.05 | 5.19 | 7.28 | 1.88 | 3.41 | 2.84 |
| Total liabilities | 757 | 631 | 365 | 278 | 225 | 185 | 151 |
| Assets | |||||||
| Gross block | 159 | 144 | 104 | 91.01 | 74.20 | 56.55 | 36.31 |
| Net block | 130 | 123 | 89.62 | 80.72 | 67.28 | 51.88 | 33.06 |
| Capital work in progress | 0.00 | 6.69 | 0.00 | 0.36 | 0.00 | 2.65 | 0.48 |
| Investments | 343 | 347 | 149 | 76.29 | 27.58 | 42.69 | 61.81 |
| Inventories | 66.42 | 53.27 | 37.40 | 37.35 | 48.48 | 21.74 | 12.93 |
| Sundry debtors | 101 | 96.53 | 109 | 73.12 | 75.15 | 57.92 | 39.08 |
| Cash & bank balances | 17.58 | 26.36 | 21.40 | 32.63 | 23.73 | 11.21 | 2.45 |
| Loans & advances | 45.30 | 27.53 | 12.48 | 12.61 | 21.04 | 17.64 | 13.84 |
| Total current assets | 231 | 204 | 180 | 156 | 168 | 109 | 68.30 |
| Total current liabilities | 54.66 | 57.71 | 63.35 | 42.87 | 45.01 | 26.93 | 20.42 |
| Net working capital | 176 | 146 | 117 | 113 | 123 | 81.58 | 47.88 |
| Total assets | 757 | 631 | 365 | 278 | 225 | 185 | 151 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 16.31 | 42.01 | 7.34 | 14.63 | (2.10) | 7.65 | 4.96 |
| Net cash from operating activities | (73.11) | 58.10 | 68.60 | 66.29 | 13.47 | (0.83) | 22.21 |
| Net cash from investing activities | 62.92 | (257) | (11.09) | (68.57) | 7.09 | (6.20) | (17.45) |
| Net cash from financing activities | 32.01 | 173 | (22.85) | (5.00) | (3.84) | (2.72) | (2.06) |
| Net change in cash | 21.82 | (25.69) | 34.66 | (7.29) | 16.73 | (9.75) | 2.69 |
| Closing cash | 17.58 | 26.36 | 21.40 | 32.63 | 23.73 | 11.21 | 2.45 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | -9.6% | +4.8% | +41.8% | +18.2% | +93.1% | +0.5% | - |
| EBITDA growth | -23.1% | -6.9% | +86.0% | +14.3% | +71.0% | +105.7% | - |
| PBT growth | -9.5% | -10.8% | +107.6% | +19.3% | +26.1% | +164.1% | -31.7% |
| Net income growth | -5.5% | -12.1% | +112.6% | +18.3% | +22.2% | +99.5% | - |
| Revenue CAGR (3Y) | +10.3% | +20.7% | +47.9% | +31.9% | +30.5% | +12.9% | +20.0% |
| EBITDA CAGR (3Y) | +10.0% | +25.6% | +53.8% | +59.0% | +29.2% | +9.8% | -6.4% |
| Profitability & leverage | |||||||
| Net income margin | +23.2% | +22.1% | +26.4% | +17.6% | +17.6% | +27.8% | +8.4% |
| Return on capital employed | +16.4% | +25.3% | +44.0% | +27.2% | +28.0% | +27.0% | +20.5% |
| Return on net worth | +13.3% | +19.7% | +35.3% | +21.2% | +21.8% | +21.9% | +12.6% |
| Debt / equity | 0.00 | 0.01 | 0.02 | 0.02 | 0.01 | 0.02 | 0.02 |
| Long-term debt / equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest cover | 0.73 | 0.60 | 0.74 | 0.99 | 1.00 | 1.07 | 2.06 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 2.62 | 3.53 | 4.29 | 3.58 | 3.83 | 2.79 | 3.85 |
| Inventory turnover | 6.63 | 9.69 | 11.21 | 6.89 | 7.12 | 7.47 | 9.64 |
| Debtors turnover | 4.01 | 4.28 | 4.61 | 3.99 | 3.76 | 2.67 | 3.50 |
| EPS (₹) | 0.79 | 8.49 | 9.99 | 4.70 | 3.97 | 3.25 | 0.97 |
| Dividend per share (₹) | 0.45 | 0.80 | 1.60 | 0.80 | 0.40 | 0.30 | 0.05 |
| Book value per share (₹) | 6.48 | 54.90 | 32.33 | 24.34 | 20.02 | 16.35 | 13.25 |
To see the full year-wise statements and ratios of Fineotex Chemical Limited, buy the company report.
Board of directors of Fineotex Chemical Limited
Fineotex Chemical has 7 current directors and 12 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Aarti Mitesh Jhunjhunwala Also directs: Leo United Industries India Private Limited | Whole-Time Director | 14 Aug 2018 | 8 Years 2 Months | Current |
| Surendra Deviprasad Tibrewala | Managing Director | 30 Jan 2004 | 22 Years 9 Months | Current |
| Sanjay Surendra Tibrewala Also directs: Finoclean Specialities Private Limited, Manya Manufacturing India Private Limited, Panchavati Constructions LLP and 1 more | Whole-Time Director | 30 Jan 2004 | 22 Years 9 Months | Current |
| Bindu Darshan Shah | Director | 14 Jul 2020 | 6 Years 3 Months | Current |
| Sunil Vasant Waghmare Also directs: FSPL Specialities Private Limited | Director | 31 Oct 2020 | 5 Years 11 Months | Current |
| Chetan Navinchandra Shah Also directs: Focus Lighting and Fixtures Limited | Director | 12 Aug 2025 | 1 Years 2 Months | Current |
Peer comparison
Fineotex Chemical Limited is compared with the 7 companies closest to it by revenue in the Chemicals industry (Specialty Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Fineotex Chemical Limitedthis company | ₹772.23 Cr (FY 2026) | ₹108.77 Cr | 14.1% | 44.8% | 92 | Mumbai, Maharashtra, India |
| H.B. Fuller India Adhesives Private Limited | ₹575.65 Cr (FY 2025) | 14.0% | Shirwal, Maharashtra, India | |||
| Dfe Pharma India Private Limited | ₹571.98 Cr (FY 2025) | 26.0% | Cuddalore, Tamil Nadu, India | |||
| Finorchem Limited | ₹558.51 Cr (FY 2025) | 3.0% | Kolkata, West Bengal, India | |||
| Benzo Chem Industries Pvt Ltd | ₹554.12 Cr (FY 2025) | 13.0% | Mumbai, Maharashtra, India | |||
| Ganga Rasayanie Pvt Ltd | ₹550.14 Cr (FY 2024) | 2.0% | Kolkata, West Bengal, India | |||
| Nitta Gelatin India Limited | ₹544.58 Cr (FY 2025) | 0.0% | Ernakulam, Kerala, India | |||
| Palvi Industries Limited | ₹543.65 Cr (FY 2025) | 43.0% | Vadodara, Gujarat, India |
To see the full peer comparison of Fineotex Chemical Limited, buy the company report.
Auditor
Fineotex Chemical Limited is audited by ASL AND CO for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ASL AND CO | FY 2024 | 101921W |
Shareholding
Shareholding for the quarter ended Sep 2026: promoters hold 62.30%, foreign institutional investors hold 3.20%, domestic institutional investors hold 1.30% and retail and other public shareholders hold 33.20%.
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | |
|---|---|---|---|---|
| Promoters | 62.30% | 62.30% | 62.60% | 62.90% |
| Public | 37.70% | 37.70% | 37.40% | 37.10% |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 18 Sep 2023 | 100780901 | Indian Bank | ₹1.81 Cr | Open | |
| 26 Apr 2023 | 100714841 | Others | ₹7.5 Cr | Open | |
| 09 Mar 2022 | 100555021 | Others | ₹30 Cr | Open | |
| 30 Oct 2020 | 100388979 | Others | ₹8 Cr | Satisfied | |
| 22 Jul 2011 | 10297232 | Export Import Bank of India Limited | ₹6.48 Cr | Satisfied |
To see the full charge records of Fineotex Chemical Limited, buy the company report.
Total charge records: 7 View all charges
Deals & funding
Fineotex Chemical Limited has 159 deals on record (156 market trades, 1 buyback, 1 funding round), with disclosed funding of ₹342.55 Cr; the latest was in May 2026.
Deals on record (5 of 159)
| When | Deal | Amount | Parties |
|---|---|---|---|
| May 2026 | Market trade | ₹58.06 Cr | Buyer: Junomoneta Finsol Private Limited , Hrti Private Limited Seller: Junomoneta Finsol Private Limited , Hrti Private Limited |
| May 2026 | Market trade | ₹41.4 Cr | Buyer: Junomoneta Finsol Private Limited , Qe Securities LLP Seller: Junomoneta Finsol Private Limited , Qe Securities LLP |
| May 2026 | Market trade | ₹121.89 Cr | Buyer: NK Securities Research Private Limited , Qe Securities LLP , Junomoneta Finsol Private Limited Seller: NK Securities Research Private Limited , Qe Securities LLP , Junomoneta Finsol Private Limited |
| Nov 2025 | Market trade | ₹54.73 Cr | Buyer: Hrti Private Limited , Junomoneta Finsol Private Limited , Qe Securities LLP Seller: Hrti Private Limited , Reliance Mutual Fund(Reliance Capital Trustee Co. Ltda/C Nippon Mutual Fund), Junomoneta Finsol Private Limited |
| Oct 2025 | Market trade | ₹5.86 Cr | Buyer: Qe Securities LLP Seller: Qe Securities LLP |
To see the full deal history of Fineotex Chemical Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Fineotex Chemical Limited has 10 court cases on record: 7 filed by Fineotex Chemical, 3 filed against it. 6 cases are pending and 4 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 5 | 3 | 3 |
| High courts | 5 | 0 | 3 |
Cases on record (5 of 10)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Commercial suit | Filed by the company against Integrated Spaces Limited and 1 other | Pending |
| Bombay High Court | Court case (NMCD) | Filed by the company against Integrated Spaces Limited and 1 other | Pending |
| District court, Thane, Maharashtra | Civil suit | Filed against the company by GT Fruitech LLP THR. Pradipta Sahu | Disposed |
| High Court, MAHARASHTRA | Interim or miscellaneous application | Filed by the company against GT Fruitech LLP THR. Its Constituted Attorney Mr. Pradipta Kishor Sahu | Disposed |
| High Court, MAHARASHTRA | Court case (AO) | Filed by the company against GT Fruitech LLP THR. Its Constituted Attorney Mr. Pradipta Kishor Sahu | Disposed |
To see the full case history of Fineotex Chemical Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Fineotex Chemical Limited was last rated by Crisil on 02 Jul 2021.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 02 Jul 2021 |
To see the full credit ratings and regulatory alerts of Fineotex Chemical Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Fineotex Chemical Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Fineotex Chemical has 3 subsidiary companies. This group structure data is as of FY 2024. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Finoclean Specialities Private Limited | U20297MH2023PTC416393 | |
| Manya Manufacturing India Private Limited | U24200MH2009PTC195660 | |
| FSPL Specialities Private Limited | U24290MH2020PTC345418 |
To see the full group structure of Fineotex Chemical Limited, buy the company report.
Employees & EPFO
Fineotex Chemical Limited has a workforce of 92 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.
GST
Fineotex Chemical has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACF8360M1Z9 | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Fineotex Chemical Limited, buy the company report.
Recent activity
Fineotex Chemical Limited has 26 board changes on record since 2004: 17 appointments and 9 cessations. The latest: Navin Bhimsen Mittal ceased to be Director on 27 Sep 2025.
30 earlier events are in the company report.
News
Frequently asked questions
Fineotex Chemical is an active public limited company based in Mumbai, Maharashtra, India. The company works in specialty chemicals, within the chemicals and materials industry. It was incorporated on 30 January 2004 (22+ years old) and is registered under CIN L24100MH2004PLC144295. Listed on BSE: 533333 and NSE: FCL.
Fineotex Chemical reported revenue of ₹772.23 Cr for FY 2025-26 (up 44.8% YoY) based on consolidated financials.
Fineotex Chemical has 7 current directors:
- Surendra Deviprasad Tibrewala - Managing Director
- Aarti Mitesh Jhunjhunwala - Whole-Time Director
- Sanjay Surendra Tibrewala - Whole-Time Director
- Bindu Darshan Shah - Director
- Sunil Vasant Waghmare - Director
- Chetan Navinchandra Shah - Director
- Amit Prabhakar Pratap - Director
The latest financial statements of Fineotex Chemical on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 11 September 2026. Year-wise statements from 2015 are in the company report.
The GSTIN of Fineotex Chemical is 27AAACF8360M1Z9, registered in Maharashtra. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Fineotex Chemical is L24100MH2004PLC144295. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. Fineotex Chemical is a listed company as per MCA records. Its shares are listed on both BSE (code: 533333) and NSE (symbol: FCL).
Fineotex Chemical has 10 court cases on record: 7 filed by the company and 3 filed against it. 6 are pending. Most are in the district courts.
Fineotex Chemical was incorporated on 30 January 2004, making it 22+ years old. It is registered with the Registrar of Companies, Mumbai.
Fineotex Chemical has 159 deals on record (156 market trades, 1 buyback, 1 funding round), with disclosed funding of ₹342.55 Cr; the latest was in May 2026.
The peers of Fineotex Chemical by revenue are H.B. Fuller India Adhesives Private Limited, Dfe Pharma India Private Limited, Finorchem Limited, Benzo Chem Industries Pvt Ltd, Ganga Rasayanie Pvt Ltd and 2 more, all in the Chemicals industry (Specialty Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).